Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

Leo Pharma to license Tanabe’s rare disease drug for pain with sun exposure

Leo Pharma said it will pay Japan’s Tanabe Pharma up to $435 million in upfront and near-term payments to license an oral drug for a pair of genetic light-sensitive skin diseases. The Danish biotech will ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

Kinew pledges temporary ER in Dauphin by Labour Day

Dauphin’s 8,400 residents, ravaged by floodwaters from unprecedented rainfall in June that has left the city without its hospital for the entire summer, will have a temporary but functioning ER […]

  • Premier Wab Kinew promises temporary ER in Dauphin by Labour Day.
  • Dauphin's 8,400 residents had no hospital after June floods.
  • Mayor David Bosiak confident in Kinew's commitment.

More from Tuesday 18 August →